I-Ven Pharma Capital Limited
About I-Ven Pharma Capital Limited
Data last updated:
I-Ven Pharma Capital Limited is a public limited company based in Bangalore, Karnataka, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 18 March 2005.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2005PLC035853.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.85 Lakh. It is led by directors including Umang Vohra and Satish Reddy Kallam.
Its last annual general meeting (AGM) was held on 18 July 2012, and its latest financial statements are for the year ended 31 March 2012. The registered office is at 39/40(P) KIADB Industrial Area Electronics City Phase II, Bangalore, Karnataka, India – 560100.
Court records list 2 cases involving the company, including 2 filed by the company. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹210.85 Cr; the latest was in March 2011.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address39/40(P) KIADB Industrial Area Electronics City Phase II, Bangalore, Karnataka, India – 560100
- IndustryChemicals, Other Chemical Product, Pharmaceutical Chemical, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of I-Ven Pharma Capital Limited
FY 2012 filings availableFinancial Statement Summary
| Metrics | FY 2011-12 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | •••• |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | •••• |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios
| Metrics | FY 2011-12 |
|---|---|
| Profitability | |
| EBITDA Margin | •••• |
| Net Profit Margin | •••• |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of I-Ven Pharma Capital are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of I-Ven Pharma Capital Limited
I-Ven Pharma Capital has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Umang Vohra | Director | 01 Oct 2010 | 16 Years 0 Months | As last reported |
| Satish Reddy Kallam Also directs: Dr.Reddy's Laboratories Ltd, Aurigene Oncology Limited, Greenpark Hotels and Resorts Limited and 5 more | Director | 01 Oct 2010 | 16 Years 0 Months | As last reported |
| Venkateswara Prasad Gunupati Also directs: Dr.Reddy's Laboratories Ltd, Aurigene Oncology Limited, Greenpark Hotels and Resorts Limited and 5 more | Director | 01 Oct 2010 | 16 Years 0 Months | As last reported |
Charges & Borrowings
I-Ven Pharma Capital Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding
I-Ven Pharma Capital Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹210.85 Cr; the latest was in March 2011.
Deals on record (4 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 4 individuals |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2008 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
I-Ven Pharma Capital Limited has 2 court cases on record: 2 filed by I-Ven Pharma Capital. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Court case (COP) | Filed by the company against Dr. Reddy's Laboratories Limited, | Disposed |
| High Court of Karnataka | Appeal | Filed by the company against an individual | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to I-Ven Pharma Capital.
: available in the company report
Recent Activity
I-Ven Pharma Capital Limited has 13 board changes on record since 2007: 3 appointments and 10 cessations. The latest: Satish Reddy Kallam ceased to be Additional Director on 21 Jul 2011.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
I-Ven Pharma Capital is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
I-Ven Pharma Capital is a company under liquidation, formerly operating as a public limited company based in Bangalore, Karnataka, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 18 March 2005 and is registered under CIN U24231KA2005PLC035853. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
I-Ven Pharma Capital has 3 current directors:
- Umang Vohra - Director
- Satish Reddy Kallam - Director
- Venkateswara Prasad Gunupati - Director
The latest financial statements of I-Ven Pharma Capital on record with the MCA are for the year ended 31 March 2012. Its last annual general meeting was held on 18 July 2012. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of I-Ven Pharma Capital is U24231KA2005PLC035853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Ven Pharma Capital has 2 court cases on record: 2 filed by the company.
I-Ven Pharma Capital was incorporated on 18 March 2005. It is registered with the Registrar of Companies, Bangalore.
I-Ven Pharma Capital has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹210.85 Cr; the latest was in March 2011.
Satish Reddy Kallam ceased to be Additional Director on 21 Jul 2011. Umang Vohra ceased to be Additional Director on 21 Jul 2011. Venkateswara Prasad Gunupati ceased to be Additional Director on 21 Jul 2011. I-Ven Pharma Capital has 13 board changes on record in total.
The registered office of I-Ven Pharma Capital is at 3940P KIADB Industrial Area Electronics City Phase II, Bangalore, Karnataka, India – 560100.